Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations

Lupus

Volumn 25, Issue 11, 2016, Pages 1260-1265

  Kampylafka, E I ^a   Alexopoulos, H ^a   Fouka, P ^a   Moutsopoulos, H M ^a   Dalakas, M C ^a,b   Tzioufas, A G ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

autoantibodies; epilepsy; neurological manifestations; NMDA receptors; Systemic lupus erythematosus

Indexed keywords

ANTICONVULSIVE AGENT; AUTOANTIBODY; CYCLOPHOSPHAMIDE; HUMAN IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MEMBRANE ANTIGEN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; RITUXIMAB; STEROID; ANTINUCLEAR ANTIBODY; BIOLOGICAL MARKER;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ACTIVITY; EPILEPSY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NERVE CELL; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; IMMUNOLOGY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PSYCHOLOGY; YOUNG ADULT;

ADULT; ANTIBODIES, ANTINUCLEAR; ANTICONVULSANTS; ANTIGENS, SURFACE; AUTOANTIBODIES; BIOMARKERS; EPILEPSY; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84987660643     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316636473     Document Type: Article

References (22)

1. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
2. Unterman A, Nolte JE, Boaz M, Abady M, Shoenfeld Y, Zandman-Goddard G. Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum 2011; 411-11.
3. Kampylafka EI, Alexopoulos H, Kosmidis ML, et al. Incidence and prevalence of major central nervous system involvement in systemic lupus erythematosus: a 3-year prospective study of 370 patients. PLoS One 2013; 8: e55843-e55843.
4. Rodriguez Cruz PM, Huda S, Lopez-Ruiz P, Vincent A,. Use of cell-based assays in myasthenia gravis and other antibody-mediated diseases. Exp Neurol 2015; 270: 66-71.
5. Leypoldt F, Armangue T, Dalmau J,. Autoimmune encephalopathies. Ann NY Acad Sci 2014; 47: 10-20.
6. Karassa FB, Afeltra A, Ambrozic A, et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 2006; 54: 312-324.
7. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B,. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7: 1189-1193.
8. Tsuchiya H, Haga S, Takahashi Y, Kano T, Ishizaka Y, Mimori A,. Identification of novel autoantibodies to GABA(B) receptors in patients with neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford) 2014; 53: 1219-1228.
9. Chang EH, Volpe BT, Mackay M, et al. Selective impairment of spatial cognition caused by autoantibodies to the N-methyl-d-aspartate receptor. E Bio Med 2015; 2: 755-764.
10. Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010; 69: 2074-2082.
11. Fouka P, Alexopoulos H, Akrivou S, Trohatou O, Politis PK, Dalakas MC,. GAD65 epitope mapping and search for novel autoantibodies in GAD-associated neurological disorders. J Neuroimmunol 2015; 281: 73-77.
12. Wright S, Hashemi K, Stasiak L, et al. Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model. Brain 2015; 138: 3159-3167.
13. Alexopoulos H, Dalakas MC,. Immunology of stiff person syndrome and other GAD-associated neurological disorders. Expert Rev Clin Immunol 2013; 9: 1043-1053.
14. Bertsias GK, Boumpas DT,. Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol 2010; 6: 358-367.
15. de Carvalho JF, Pasoto SG, Appenzeller S. Seizures in primary antiphospholipid syndrome: the relevance of smoking to stroke. Clin Dev Immunol 2012; 981519.
16. Appenzeller S, Cendes F, Costallat LT,. Epileptic seizures in systemic lupus erythematosus. Neurology 2004; 63: 1808-1812.
17. Andrade RM, Alarcon GS, Gonzalez LA, et al. Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). Ann Rheum Dis 2008; 67: 829-834.
18. Arinuma Y, Yanagida T, Hirohata S,. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2008; 58: 1130-1135.
19. Husebye ES, Sthoeger ZM, Dayan M, et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 1210-1213.
20. Fragoso-Loyo H, Cabiedes J, Orozco-Narvaez A, et al. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One 2008; 3: e3347-e3347.
21. Hirohata S, Arinuma Y, Yanagida T, Yoshio T,. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther 2014; 16: R77-R77.
22. Hanly JG, Urowitz MB, Su L, et al. Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. Ann Rheum Dis 2012; 71: 1502-1509.